Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3677923012 | Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3726282016 | Product containing precisely dabrafenib (as dabrafenib mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3726283014 | Dabrafenib (as dabrafenib mesilate) 75 mg oral capsule | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Is a | Dabrafenib only product in oral dose form | true | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Is a | Dabrafenib-containing product | false | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has active ingredient | Dabrafenib mesilate | false | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has active ingredient | Dabrafenib mesilate | false | Inferred relationship | Some | 1 | |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has BoSS | Dabrafenib | true | Inferred relationship | Some | 1 | |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has presentation strength numerator value | 75 | false | Inferred relationship | Some | 1 | |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 1 | |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has active ingredient | Dabrafenib | false | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Has precise active ingredient | Dabrafenib mesilate | true | Inferred relationship | Some | 1 | |
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Is a | Dabrafenib-containing product in oral dose form | false | Inferred relationship | Some | ||
| Dabrafenib (as dabrafenib mesylate) 75 mg oral capsule | Count of base of active ingredient | 1 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR